Dr Sam Behjati wins Liddy Shriver Early Career Research Award

Congratulations to Sanger Institute cancer researcher, Dr Sam Behjati, who has been recognised for his work in sarcoma cancer genomics

Dr Sam Behjati wins Liddy Shriver Early Career Research Award

Dr Sam Behjati wins Liddy Shriver Early Career Research Award

Dr Sam Behjati has received this year’s Liddy Shriver Early Career Research Award, given by the Connective Tissue Oncology Society (CTOS). The Award highlights Dr Behjati’s internationally recognised, outstanding contributions as an early-career researcher working in the sarcoma field.

Sarcomas are rare cancers that affect bone and soft tissue, including muscle, tendons and blood vessels. Over 5,000 people are diagnosed with sarcoma every year in the UK alone*.

Dr Behjati’s work has focused on the basic cancer genomics of human sarcoma, helping to understand the genetic events that give rise to bone and cartilage diseases such as osteoblastoma, osteosarcoma and chondrosarcoma.

To recognise Dr Behjati’s outstanding contributions to sarcoma research, he was awarded the Liddy Shriver Early Career Research Award by CTOS after being nominated by two Wellcome Sanger Institute colleagues, Dr Peter Campbell and Dr Sarah Teichmann, as well as a colleague from the UCL Cancer Institute, Professor Adrienne Flanagan.

The Liddy Shriver Early Career Research Award was created in 2017 by the Liddy Shriver Sarcoma Initiative, whose mission is to promote sarcoma awareness, fund research, and support patients and their loved ones. It is named after Elizabeth (Liddy) Shriver, who was diagnosed with Ewing's sarcoma in 2002, succumbing to the disease in 2004. She was 37-years old.

The Award aims to engender dialogue and collaboration between recipients and their colleagues from around the world. As the recipient of this year’s Award, Dr Behjati was invited to give a lecture at the CTOS Annual Meeting, reflecting his anticipated future research in the field of sarcoma. He will also receive 50,000 USD to fund further research into sarcomas.

“It is a privilege and honour to receive the Liddy Shriver Early Career Research Award. I am most grateful to my brilliant colleagues and collaborators who have supported my work over the years. It is only by working together that we will be able to improve outcomes for those affected by sarcomas.”

Dr Sam Behjati, Wellcome Sanger Institute

“CTOS is proud to honour the contributions of Bruce and Beverly Shriver to those affected by sarcomas, through offering the prestigious Liddy Shriver Sarcoma Award each year to an outstanding early career researcher. We are delighted to announce that the 2019 recipient is Dr Sam Behjati.”

Connective Tissue Oncology Society

The Award was announced on 16 November at the CTOS Annual Meeting 2019 in Tokyo, Japan.

Notes to Editors

*For more information on sarcoma, see the Sarcoma UK website: https://sarcoma.org.uk/about-sarcoma/understanding-sarcoma-0

Selected Websites
Caring for children with cancerSanger LifeCaring for children with cancer
We explore the world of award-winning cancer scientist, Dr Sam Behjati

Role of Cancer GenesVideoRole of Cancer Genes
This flash animation shows you how DNA mutations are involved in the development of cancer. 

Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
CB10 1SA,

Mobile +44 (0) 7748 379849

Recent News

Origins of immune system mapped, opening doors for new cancer immunotherapies
Cell atlas of human thymus could help engineer improved therapeutic T cells
Otter genome to help understand genetic legacy of pollution crisis and secure species’ future
Genome will unlock wealth of data stored in DNA archives in bid to understand response to environmental changes
Gut bacteria’s interactions with immune system mapped
Cell atlas could reveal why some gut diseases affect specific areas